Published in Cancer Weekly, July 6th, 2004
Mercer succeeds Michael Klein, who resigned from R2 Technology.
"We want to thank Mike Klein for his leadership over the past 4 years as the company has grown from $5 million to almost $60 million in revenues," Mercer said.
"Companies go through different phases of development and R2 Technology is no exception. As we strive to take R2 Technology towards its next phase as a full-fledged medical software company requiring heavy involvement in the soft copy or digital environment, Mike and the board...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.